Working concentrations for specific applications should be determined by the investigator. The appropriate concentrations may be affected by secondary antibody affinity, antigen concentration, the sensitivity of the method of detection, temperature, the length of the incubations, and other factors. The suitability of this antibody for applications other than those listed below has not been determined. The following concentration ranges are recommended starting points for this product. Western blot: 0.5-1 µg/mLOther Applications: user-optimized
Restrictions
For Research Use only
Format
Lyophilized
Buffer
PBS, pH 7.4, containing 0.02 % sodium azide
Preservative
Sodium azide
Precaution of Use
WARNING: Reagents contain sodium azide. Sodium azide is very toxic if ingested or inhaled. Avoid contact with skin, eyes, or clothing. Wear eye or face protection when handling. If skin or eye contact occurs, wash with copious amounts of water. If ingested or inhaled, contact a physician immediately. Sodium azide yields toxic hydrazoic acid under acidic conditions. Dilute azide-containing compounds in running water before discarding to avoid accumulation of potentially explosive deposits in lead or copper plumbing.
Storage
4 °C/-20 °C
Storage Comment
The antibody is stable in lyophilized form if stored at -20°C or below. The reconstituted antibody can be stored for 2-3 weeks at 2-8°C. For long term storage, aliquot and store at -20°C or below. Avoid repeated freezing and thawing cycles.
CXCR4 is one member of G-protein coupled receptor that contains seven transmembrane spanning. CXCR4 is a principal coreceptor for T cell tropic strains of HIV1 fusion and entry of human white blood cells. It is also required for the infection by dual-tropic strains of HIV1 and mediates CD4 independent infection by HIV2. Chemokine SDF1 is the ligand for CXCR4 that prevents infection by T tropic HIV. CXCR4 is highly expressed in brain, heart, white blood cells, vascular endothelial cells, and umbilical cord endothelial cells.Rabbit Anti-CXCR4 Polyclonal Antibody is developed in rabbit using a KLH-coupled synthetic peptide from N-terminal of human CXCR4 (Swiss Prot: P61073).